Join to View Full Profile
1021 Morehead Medical DrSte ACharlotte, NC 28204
Phone+1 980-442-2000
Dr. Mileham is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Vanderbilt University Medical CenterFellowship, Hematology and Medical Oncology, 2006 - 2009- Vanderbilt University Medical CenterResidency, Internal Medicine, 2003 - 2006
Medical University of South CarolinaClass of 2003
Certifications & Licensure
NC State Medical License 2009 - 2026
TN State Medical License 2006 - 2010
American Board of Internal Medicine Medical Oncology
Clinical Trials
- Early Diagnosis of Pulmonary Nodules Start of enrollment: 2012 Oct 01
- LCI-LUN-ABR-001: Carbo With Nab-Paclitaxel in Patients With Advanced NSCL Cancer Start of enrollment: 2014 Dec 01
- A Study of Ramucirumab (LY3009806) in Combination With Erlotinib in Previously Untreated Participants With EGFR Mutation-Positive Metastatic NSCLC (RELAY) Start of enrollment: 2015 May 06
Publications & Presentations
PubMed
- Olaparib in Patients With Solid Tumors WithAlterations: Results From The Targeted Agent and Profiling Utilization Registry (TAPUR) Study.Tareq Al Baghdadi, Michael Rothe, Pam K Mangat, Elizabeth Garrett-Mayer, Oxana V Crysler
JCO Precision Oncology. 2025-10-01 - 2 citationsIASLC grading system predicts distant metastases for resected lung adenocarcinoma.Yuezhu Wang, Margaret R Smith, Caroline B Dixon, Ralph D'Agostino, Yin Liu
Journal of Clinical Pathology. 2025-05-25 - Refining multimodal strategies for locally advanced NSCLC - Authors' reply.John H Heinzerling, Kathryn F Mileham, Myra M Robinson, Charles B Simone 2nd
The Lancet. Oncology. 2025-03-01
Authored Content
- Moving Away (Finally) from Doublet Therapy in Lung Cancer: Immunotherapy and KEYNOTE-189September 2018
Press Mentions
COVID-19 Mortality Risk Higher Among Older Patients with B-cell MalignanciesJanuary 6th, 2022- GeneCentric Therapeutics Identifies RNA-Based Genomic Markers of Clinical Response in Lung CancerDecember 21st, 2021
Targeted Therapy for Mutation-Driven Metastatic Non–Small-Cell Lung Cancer: Considerations for ALK-Rearranged TumorsApril 15th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
